Search for: "The Regulatory Review" Results 9141 - 9160 of 28,267
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
3 Jun 2024, 9:06 pm by Cookson Beecher
The Food and Agriculture Organization, which has reviewed food safety issues related to gene editing, points out that although approaches may vary, many countries have found a way to include gene-edited foods in the existing regulatory category to handle such issues. [read post]
19 May 2024, 7:12 am by David Oxenford and Keenan Adamchak
The Senate Committee on Rules Administration held a hearing in which in reviewed three bills addressing the effect of artificial intelligence (AI) on elections. [read post]
14 Jul 2024, 6:19 am by David Oxenford and Keenan Adamchak
Here are some of the regulatory developments of significance to broadcasters from this past week, with links to where you can go to find more information as to how these actions may affect your operations. [read post]
18 Jan 2010, 3:20 am by Sean Wajert
"   Last summer, the Commissioner of the Food and Drug Administration reversed existing, sound policy that required prior legal review of regulatory letters (Untitled and Warning Letters) by the Agency's Office of Chief Counsel. [read post]
15 Mar 2018, 9:30 pm by Sarah Madigan
Senate voted 67-31 to pass the bipartisan Economic Growth, Regulatory Relief, and Consumer Protection Act. [read post]
This past week, several consumer and regulatory actions made headlines: Federal Guidance D.C. [read post]
20 May 2008, 5:25 pm
DATES: To allow us adequate time to conduct this review, we request that information be submitted on or before July 7, 2008. [read post]
21 Oct 2009, 5:13 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US: Senate Judiciary Committee passes bill against "pay for delay" drug settlements (Prior Art) (Patently-O) (Patent Docs) Valcyte (Valganciclovir) - US: District Court New Jersey finds Roche's Valcyte patent valid and not infringed by Ranbaxy (Patent Docs) (GenericsWeb) General Médecins Sans Frontiéres calls on drug… [read post]
19 Dec 2011, 2:56 pm by James Hamilton
They also maintain that state law developments, such as the validity of poison pills and staggered boards, have tilted the regulatory balance towards issuers. [read post]
9 Apr 2009, 7:52 am
(IP Think Tank) Brazilian public-private partnerships in the pharma industry (IP tango) EU: ECJ to rule on reference on SPC Regulation interpretation from Lithuania in Kirin Amgen, Inc. v Lietuvos Respublikos valstybinis patentų biuras (The SPC Blog) India: Delhi High Court Dasatinib order: Is patent-drug regulatory linkage a necessity? [read post]
21 Oct 2009, 5:13 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US: Senate Judiciary Committee passes bill against "pay for delay" drug settlements (Prior Art) (Patently-O) (Patent Docs) Valcyte (Valganciclovir) - US: District Court New Jersey finds Roche's Valcyte patent valid and not infringed by Ranbaxy (Patent Docs) (GenericsWeb) General Médecins Sans Frontiéres calls on drug… [read post]
21 Oct 2009, 6:13 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: US: Senate Judiciary Committee passes bill against “pay for delay” drug settlements (Prior Art) (Patently-O) (Patent Docs) Valcyte (Valganciclovir) – US: District Court New Jersey finds Roche’s Valcyte patent valid and not infringed by Ranbaxy (Patent Docs) (GenericsWeb)   General… [read post]
22 Feb 2011, 9:01 am by Tom Kosakowski
The position is responsible for conducting reviews and investigations related to complaints received by the FINRA Ombuds, as well as working with senior managers to ensure appropriate resolution to any issue that arise.Applicants should have a bachelor’s degree and a minimum of five years experience in a compliance, analytical or investigative role; and strong knowledge of securities industry rules or relevant securities industry experience. [read post]
7 Dec 2009, 3:32 pm by Tom Kosakowski
The Associate Director is responsible for conducting reviews and investigations related to complaints received by the Office of the Ombudsman, as well as working with senior managers to ensure appropriate resolution to any issue that arise. [read post]
15 Jul 2010, 11:15 am by Stikeman Elliott LLP
This would involve analyzing trends in the economic and market environment to identify potential risks to consumers, examining firms' business models to understand the drivers of profitability, reviewing whether firms have product development and approval processes that weed out innappropriately marketed or harmful products and taking action to ensure customers are protected where incentives, structures or products are found that would likely lead to poor customer outcomes. [read post]
2 Jun 2010, 12:35 pm by Dan
Firms are encouraged to review the proposal and submit feedback prior to August 20, 2010. [read post]
29 Jun 2021, 4:09 pm by INFORRM
Journalistic or editorial content will not be affected by the regulatory framework. [read post]